Home / Health / New DNA Test Predicts Breast Cancer Treatment Success
New DNA Test Predicts Breast Cancer Treatment Success
18 Jan
Summary
- Simple DNA blood test predicts patient response to breast cancer treatment.
- Liquid biopsy analyzes circulating tumor DNA for early prediction.
- Test may help patients avoid ineffective treatments, improving outcomes.
A revolutionary DNA blood test has been developed by researchers, offering the potential to transform breast cancer treatment. This simple liquid biopsy analyzes circulating tumor DNA (ctDNA) released into the bloodstream by cancer cells, providing an early prediction of a patient's response to therapy. The test, trialled on 167 patients with advanced breast cancer, showed a strong association between low ctDNA levels and positive treatment outcomes.
This innovative approach means that patients could be offered the most effective treatment from the outset, avoiding therapies unlikely to work and potentially preventing cancer growth. For instance, individuals could receive alternative targeted therapies, drug combinations, or be enrolled in clinical trials based on these early blood test results. Trials are currently underway to confirm if adapting treatment based on these findings improves patient outcomes.
The research, which focused on advanced breast cancer, suggests these tests could also be applicable to early-stage cases. By making treatment decisions faster, more personalized, and ultimately more effective, this liquid biopsy holds significant promise for improving survival rates and the well-being of breast cancer patients globally.
